Virtus Investment Advisers »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $44k 47k 0.94
2023-12-31 $46k 47k 0.98

More positions owned by Virtus Investment Advisers

Pimco Etf Tr Enhancd Short (EMNT)
Virtus Etf Tr Ii Duff & Phelps Cl (VCLN)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Icici Bank Adr (IBN)
Vipshop Hldgs Sponsored Ads A (VIPS)
Apple (AAPL)
Taylor Morrison Hom (TMHC)
Barrett Business Services (BBSI)
Super Micro Computer (SMCI)
Janus International Group In Common Stock (JBI)
Prestige Brands Holdings (PBH)
Rush Enterprises Cl A (RUSHA)
Warrior Met Coal (HCC)
Blackline (BL)

View all positions for Virtus Investment Advisers

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Deerfield Management Company
Aequim Alternative Investments
Lazard Asset Management
BlackRock
Davidson Kempner Capital Management
Calamos Advisors
Invesco
BlackRock
State Street Corporation
Morgan Stanley
MacKay Shields
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1